Skip to main content

Urology Research Led By Science

Partnered with our country’s leading urologists, where together, we have created premier clinical research centers across the country. Our research programs offer unparalleled access to new cutting-edge treatment options for both urologists and their patients.

CONTACT US

Urologic Conditions that Impacts Millions

Today, 1 in 5 Americans suffer from urologic conditions and it is estimated that it costs the US healthcare system $11 billion annually in medical preventative and oncology care. Urologic cancers are the most commonly diagnosed in the US, with prostate cancer being the second leading cause of cancer death among men. To combat these statistics, Urologists need a trusted research partnership platform to find initial therapies for urological disease states.

Our Urology Research Areas:

ObjectiveHealth is currently conducting clinical trials in the following urologic disease states and conditions:

546M
impacted by

OVERACTIVE BLADDER

150M
impacted by

URINARY TRACT INFECTIONS

94M
impacted by

BENIGN PROSTATIC HYPERPLASIA

88M
impacted by

KIDNEY STONE DISEASE

1.3M
impacted by

PROSTATE CANCER

600K
impacted by

BLADDER CANCER

 

Accelerating Research through Digital Health Technology

By utilizing our unique integrated electronic health record access, we apply ObjectiveHealth technology and health algorithms to find the right urology patients for the right trials, optimize trial outcomes, and better support patients in trial participation.

Learn More